CN106266830A - A kind of Chinese medicine composition treating eczema - Google Patents
A kind of Chinese medicine composition treating eczema Download PDFInfo
- Publication number
- CN106266830A CN106266830A CN201610803106.4A CN201610803106A CN106266830A CN 106266830 A CN106266830 A CN 106266830A CN 201610803106 A CN201610803106 A CN 201610803106A CN 106266830 A CN106266830 A CN 106266830A
- Authority
- CN
- China
- Prior art keywords
- parts
- eczema
- chinese medicine
- medicine composition
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种治疗湿疹的中药组合物。The invention relates to a traditional Chinese medicine composition for treating eczema.
背景技术Background technique
湿疹(eczema)是由多种内外因素引起的真皮浅层及表皮炎症,皮损对称分布,多形损害,剧烈瘙痒,有渗出倾向,反复发作易成慢性。Eczema is an inflammation of the superficial dermis and epidermis caused by a variety of internal and external factors. The skin lesions are distributed symmetrically, with polymorphic lesions, severe itching, and a tendency to exudate. Repeated attacks can easily become chronic.
湿疹的发病机制尚不清楚。内部因素可由慢性感染病灶、内分泌及代谢改变、血液循环障碍、神经精神因素、遗传因素等。其中遗传因素与个体易感性有关。外部因素可由失误、吸入物、生活环境、动物皮毛、各种化学所诱发或加重。某些患者可能由迟发型超敏反应介导。The pathogenesis of eczema is unclear. Internal factors can include chronic infection lesions, endocrine and metabolic changes, blood circulation disorders, neuropsychiatric factors, genetic factors, etc. Among them, genetic factors are related to individual susceptibility. External factors can be induced or aggravated by mistakes, inhalation, living environment, animal fur, and various chemicals. May be mediated by delayed-type hypersensitivity in some patients.
西医治疗湿疹以注射钙剂、维生素C、硫代硫酸钠或普鲁卡因封闭,继发感染者加用抗生素。局部外用糖皮质激素硼酸溶液等,但都存在不同的副反应,不宜长期使用,停药后易复发。Western medicine treats eczema with injection of calcium, vitamin C, sodium thiosulfate or procaine to seal it, and antibiotics are added for secondary infection. Topical glucocorticoid boric acid solution, etc., but there are different side effects, should not be used for a long time, easy to relapse after drug withdrawal.
因此,对于湿疹而言,目前临床上需要更为有效、副作用更小的治疗药物。Therefore, for eczema, there is a clinical need for more effective therapeutic drugs with less side effects.
发明内容Contents of the invention
为解决上述问题,本发明提供了一种治疗湿疹的中药组合物,它是含有下述重量配比的原料制备而成:In order to solve the above problems, the invention provides a Chinese medicinal composition for the treatment of eczema, which is prepared from raw materials containing the following weight ratios:
苍术20-25份、黄柏20-25份、苦参30-35份、白鲜皮30-35份、土茯苓30-35份、地肤子30-35份、蛇床子30-35份、五倍子20-25份。20-25 parts of atractylodes, 20-25 parts of Cortex Phellodendri, 30-35 parts of Sophora flavescens, 30-35 parts of white fresh skin, 30-35 parts of Smilax, 30-35 parts of Kochia, 30-35 parts of Cnidium, gallnut 20-25 servings.
进一步地,它是由如下重量配比的原料药制备而成的制剂:Further, it is a preparation prepared from raw materials with the following weight ratio:
苍术20-25份、黄柏20-25份、苦参30-35份、白鲜皮30-35份、土茯苓30-35份、地肤子30-35份、蛇床子30-35份、五倍子20-25份。20-25 parts of atractylodes, 20-25 parts of Cortex Phellodendri, 30-35 parts of Sophora flavescens, 30-35 parts of white fresh skin, 30-35 parts of Smilax, 30-35 parts of Kochia, 30-35 parts of Cnidium, gallnut 20-25 servings.
进一步地,它是由如下重量配比的原料药制备而成的制剂:Further, it is a preparation prepared from raw materials with the following weight ratio:
苍术20份、黄柏20份、苦参30份、白鲜皮30份、土茯苓30份、地肤子30份、蛇床子30份、五倍子20份。20 parts of Atractylodes atractylodes, 20 parts of Cortex Phellodendri, 30 parts of Sophora flavescens, 30 parts of white fresh skin, 30 parts of Smilax cocos, 30 parts of Kochia chinensis, 30 parts of Cnidium chinensis, 20 parts of Galla chinensis.
进一步地,它是由原料药的药粉、原料药的水或有机溶剂提取物为活性成分,加上药品中常用的辅料或者辅助性成分制备而成的制剂。Furthermore, it is a preparation prepared by using active ingredients of drug powder of raw materials, water or organic solvent extracts of raw materials, and adding auxiliary materials or auxiliary ingredients commonly used in medicines.
进一步地,所述制剂为外用制剂;优选的,所述外用制剂为汤剂、酊剂、膏剂、凝胶剂、散剂、搽剂、糊剂或洗剂。Further, the preparation is an external preparation; preferably, the external preparation is a decoction, tincture, ointment, gel, powder, liniment, paste or lotion.
本发明还提供了前述中药组合物的方法,它包括如下步骤:The present invention also provides the method of aforementioned Chinese medicine composition, and it comprises the steps:
(1)按重量配比称取各原料;(1) take each raw material by weight ratio;
(2)将所述原料加水提取,取水提液。(2) adding water to extract the raw material, and taking the water extract.
进一步地,步骤(2)中,所述提取方法选自水煎。Further, in step (2), the extraction method is selected from water decoction.
本发明还提供了前述中药组合物在制备治疗湿疹的药物中的用途。The present invention also provides the application of the aforementioned traditional Chinese medicine composition in the preparation of medicaments for treating eczema.
进一步地,所述湿疹为肛周湿疹。Further, the eczema is perianal eczema.
进一步地,所述湿疹为湿热内蕴型湿疹。Further, the eczema is damp-heat intrinsic type eczema.
临床实验表明,本发明药物组合物对湿疹患者,尤其是肛周湿疹病患者病情疗效显著,毒副作用小,具有独特的优势和较好的临床应用前景。Clinical experiments show that the pharmaceutical composition of the present invention has significant curative effect on eczema patients, especially perianal eczema patients, has little toxic and side effects, and has unique advantages and good clinical application prospects.
显然,根据本发明的上述内容,按照本领域的普通技术知识和惯用手段,在不脱离本发明上述基本技术思想前提下,还可以做出其它多种形式的修改、替换或变更。Apparently, according to the above content of the present invention, according to common technical knowledge and conventional means in this field, without departing from the above basic technical idea of the present invention, other various forms of modification, replacement or change can also be made.
以下通过实施例形式的具体实施方式,对本发明的上述内容再作进一步的详细说明。但不应将此理解为本发明上述主题的范围仅限于以下的实例。凡基于本发明上述内容所实现的技术均属于本发明的范围。The above-mentioned content of the present invention will be further described in detail below through specific implementation in the form of examples. However, this should not be construed as limiting the scope of the above-mentioned subject matter of the present invention to the following examples. All technologies realized based on the above contents of the present invention belong to the scope of the present invention.
具体实施方式detailed description
实施例1本发明药物的制备The preparation of embodiment 1 medicine of the present invention
1、处方:苍术20g、黄柏20g、苦参30g、白鲜皮30g、土茯苓30g、地肤子30g、蛇床子30g、五倍子20g。1. Prescription: Atractylodes 20g, Cortex Phellodendri 20g, Sophora flavescens 30g, Fresh Cortex 30g, Smilax Smilax 30g, Kochia chinensis 30g, Cnidium 30g, Galla chinensis 20g.
2、取处方量的各原料,煎煮前先加清水1000mL搅拌后浸泡30分钟左右,煎煮2次,先以武火(急火)煮沸后文火(慢火)保持煮沸状态,从沸腾时开始计时煎煮30分钟,第二煎20分钟,取汁约300mL。2. Take the raw materials of the prescribed amount, add 1000mL of water before cooking, stir, soak for about 30 minutes, and cook twice. Boil for 30 minutes, fry for 20 minutes for the second time, and take about 300mL of juice.
使用方法:加清水煮开,先熏患处,水温适宜后再湿敷、浸泡患处,早晚各1次。How to use: Add clear water to boil, fumigate the affected area first, then wet compress and soak the affected area when the water temperature is suitable, once in the morning and in the evening.
实施例2本发明药物的制备The preparation of embodiment 2 medicines of the present invention
1、处方:苍术20g、黄柏20g、苦参30g、白鲜皮30g、土茯苓30g、地肤子30g、蛇床子30g、五倍子20g。1. Prescription: Atractylodes 20g, Cortex Phellodendri 20g, Sophora flavescens 30g, Fresh Cortex 30g, Smilax Smilax 30g, Kochia chinensis 30g, Cnidium 30g, Galla chinensis 20g.
2、取处方量的各原料,煎煮前先加清水1000mL搅拌后浸泡30分钟左右,煎煮2次,先以武火(急火)煮沸后文火(慢火)保持煮沸状态,从沸腾时开始计时煎煮30分钟,第二煎20分钟,取汁约300mL。2. Take the raw materials of the prescribed amount, add 1000mL of water before cooking, stir, soak for about 30 minutes, and cook twice. Boil for 30 minutes, fry for 20 minutes for the second time, and take about 300mL of juice.
使用方法:加清水煮开,先熏患处,水温适宜后再湿敷、浸泡患处,早晚各1次。How to use: Add clear water to boil, fumigate the affected area first, then wet compress and soak the affected area when the water temperature is suitable, once in the morning and in the evening.
以下通过具体试验例证明本发明的有益效果。The beneficial effects of the present invention are demonstrated through specific test examples below.
试验例1临床病例统计Test example 1 clinical case statistics
(一)收治患者标准(或诊断标准)(1) Criteria for admitted patients (or diagnostic criteria)
患者性别及年龄范围:患者90例,年龄18-65岁,女性39例,男性51例,总病程最短2月,最长2年,治疗时间最短1月,最长半年。Gender and age range of patients: 90 patients, aged 18-65 years, 39 females, 51 males, the shortest duration of disease is 2 months, the longest is 2 years, the shortest treatment time is 1 month, and the longest is half a year.
诊断标准:Diagnostic criteria:
瘙痒剧烈、多形性、对称性皮损,急性期有渗出倾向,慢性期苔藓样变皮损。一般分为急性湿疹、亚急性湿疹、慢性湿疹。Severe itching, pleomorphic, symmetrical skin lesions, exudative tendency in the acute phase, and lichenification in the chronic phase. Generally divided into acute eczema, subacute eczema, chronic eczema.
急性湿疹好发于面、耳、手、足、前臂、小腿等暴露部位,严重者可弥漫全身,常对称分布。皮损多形性,常表现为红斑基础上的针头至粟粒大小丘疹、丘疱疹、严重者可出现小水疱,常融合成片,境界不清楚,皮损周边丘疱疹逐渐稀疏,常因搔抓形成点状糜烂面,有明显浆液性渗出。自觉瘙痒剧烈,搔抓、热水洗烫时可加重皮损。Acute eczema tends to occur in exposed parts such as the face, ears, hands, feet, forearms, and lower legs. In severe cases, it can diffuse throughout the body, often symmetrically distributed. Pleomorphic skin lesions, often manifested as pinhead to miliary-sized papules and papules on the basis of erythema, and in severe cases, small blisters may appear, often fused into sheets, with unclear borders, and papules around the skin lesion gradually become sparse, often due to scratching A punctate erosion surface was formed, with obvious serous exudation. Consciously itching is severe, and skin lesions can be aggravated when scratching or washing with hot water.
亚急性湿疹是因急性湿疹炎症减轻或不适当处理后病程较久发展而来。表现为红肿及渗出减轻,但仍可有丘疹及少量丘疱疹,皮损成暗红色,可有少许鳞屑及轻度浸润。仍自觉有剧烈瘙痒。再次暴露于致敏原、新的刺激或处理不当可导致急性发作,如经久不愈,则可发展为慢性湿疹。Subacute eczema develops for a long time after the acute eczema inflammation is alleviated or improperly handled. The redness and swelling and exudation are relieved, but there may still be papules and a small amount of papules, the skin lesions become dark red, and there may be a little scale and mild infiltration. Still consciously have severe itching. Re-exposure to allergens, new stimuli, or mismanagement can lead to acute attacks, which can develop into chronic eczema if left untreated.
慢性湿疹是由急性湿疹或亚急性湿疹迁延而来,也可由于刺激轻微、持续而一开始就表现为慢性化。好发于手足小腿肘窝股部乳房、外阴、肛门等处,对对称发病。表现为患部皮肤浸润性暗红斑上有丘疹、抓痕及鳞屑,局部皮肤肥厚、表面粗糙,有不同程度苔藓样变、色素沉着获色素减退。自觉有明显瘙痒,常呈阵发性。病情时轻时重,延续数月或更久。Chronic eczema is caused by acute eczema or subacute eczema, and it can also be chronic due to slight and persistent stimulation. Occurs in hands, feet, legs, elbow fossa, thigh, vulva, anus, etc., symmetrically. It is manifested as infiltrating dark erythema of the affected skin with papules, scratches and scales, local skin hypertrophy, rough surface, lichenification, pigmentation and hypopigmentation in different degrees. Consciously have obvious itching, often showing paroxysmal. The condition is mild and severe, and lasts for several months or longer.
(二)治疗标准(2) Standard of treatment
(1)参考赵辨提出的改良EASI评分法,就红斑、硬肿(水肿)/丘疹、表皮剥脱、苔藓化、渗出/结痂五个项目比较实验前后的疗效。具体方法如下:(1) Referring to the modified EASI scoring method proposed by Zhao Bian, compare the curative effects before and after the experiment on five items of erythema, hard swelling (edema)/papule, exfoliation, lichenification, and exudation/scab. The specific method is as follows:
E:红斑一红色或暗红色炎症性斑,压之褪色;E: Erythema—red or dark red inflammatory spot, which fades under pressure;
I:硬肿(水肿)/丘疹一皮损为有针头大小的丘疹或丘炮疹,或隆起的红色斑块;I: Induration (edema)/papules—skin lesions are pinhead-sized papules or papules, or raised red plaques;
Ex:表皮剥脱一搔抓的表皮损伤,包括在角化皮损上皲裂及皮损上的线状糜烂;Ex: exfoliation - epidermal injury from scratching, including fissures on keratinized lesions and linear erosions on lesions;
L:苔藓化一皮损为浸润肥厚,角化过度。L: Lichenification-a skin lesion is infiltrated hypertrophy and hyperkeratosis.
Ef:渗出/结痂一皮损表面湿润,包括渗液干燥后的结痴。Ef: Exudation/crustation—the surface of the lesion is wet, including crusting after the exudate has dried.
各项临床表现的严重程度以0~3分计分,0=无,1=轻,2=中,3=重。各种症状分值之间可记半级分,即0.5 0。The severity of each clinical manifestation is scored from 0 to 3 points, 0=none, 1=mild, 2=moderate, 3=severe. Half fractions can be recorded between the scores of various symptoms, that is, 0.5 0.
临床表面积大小评分:皮损大小计算用患者手掌为1%估算。皮损面积占各部位面积的比例分值为0~6,即0为无皮疹,1为<10%,2为10%~19%,3为20~49%,4为50~69%,为70~89%,6为90~100%。由于8岁以上人体,上肢与下肢的表面积分别占人体20%及40%,故比较上肢及下肢内外侧时,分别将上肢外、内侧的得分x0.1,下肢外、内侧的得分x0.2,以方便比较。Clinical Surface Area Size Score: Lesion size was calculated using 1% of the palm of the patient's hand. The ratio of skin lesion area to the area of each part is 0-6, that is, 0 means no rash, 1 means <10%, 2 means 10%-19%, 3 means 20-49%, 4 means 50-69%, 70-89%, 6 is 90-100%. Since the upper limbs and lower limbs account for 20% and 40% of the human body’s surface area respectively, when comparing the inner and outer sides of the upper limbs and lower limbs, the scores of the outer and inner sides of the upper limbs are x0.1, and the scores of the outer and inner sides of the lower limbs are x0.2 , for easy comparison.
疗效评价:根据治疗前后EASI评分的变化,按“疗效=(治疗前评分一治疗后评分)/治疗前评分x 100%”计算。痊愈:疗效≥90%;显效:90%>疗效≥50%;有效:50%>疗效≥30%;无效:疗效<30%。Efficacy evaluation: According to the change of EASI score before and after treatment, it is calculated according to "curative effect = (score before treatment - score after treatment)/score before treatment x 100%". Cured: curative effect ≥ 90%; markedly effective: 90% > curative effect ≥ 50%; effective: 50% > curative effect ≥ 30%; invalid: curative effect < 30%.
(2)搔痒程度评分用以下的标准评分:(2) The degree of itching is scored using the following criteria:
0分:无任何瘙痒;0 points: no itching;
1分:偶尔瘙痒,不需要用药,不影响学习生活;1 point: Occasional itching, no need for medication, does not affect study and life;
2分:阵发性瘙痒,时轻时重,影响睡眠学习生活;2 points: paroxysmal itching, sometimes mild and sometimes severe, affecting sleep, study and life;
3分:剧烈瘙痒,严重影响工作学习生活。3 points: severe itching, seriously affecting work, study and life.
各种症状分值之间可一记半级分,即0.5。There can be one and a half points between the scores of various symptoms, that is, 0.5.
(3)采用皮肤病生活质量指标调查表((DLQI)评估治疗对患者生活质量。(3) Dermatology Life Quality Index Inventory (DLQI) was used to evaluate the effect of treatment on the quality of life of patients.
(三)治疗方法(3) Treatment methods
1、给药方法:明确诊断后,90例患者均采用如下药物:苍术20g、黄柏20g、苦参30g、白鲜皮30g、土茯苓30g、地肤子30g、蛇床子30g、五倍子20g。1. Administration method: After the diagnosis was made, 90 patients were given the following medicines: 20g of Atractylodes atractylodes, 20g of Phellodendron Phellodendri, 30g of Sophora flavescens, 30g of Radix Cortex, 30g of Smilax, 30g of Kochia chinensis, 30g of Cnidium chinensis, and 20g of Galla chinensis.
每日1剂,水煎3次,早、晚各1次熏患处,水温适宜后再湿敷、浸泡患处,连用2周。治疗期间,不配有其它西药和其它疗法。Take 1 dose per day, decoct 3 times in water, fumigate the affected area once in the morning and 1 time in the evening, apply wet compress and soak the affected area after the water temperature is suitable, and use continuously for 2 weeks. During the treatment period, no other western medicine and other treatments are provided.
治疗期间饮食清淡,忌肥甘厚味,忌甜食、海鲜食物及热性水果,嘱多食蔬菜。忌热水烫洗,忌肥皂等此疾物洗患处。避免抓挠,以防止感染。During the treatment period, the diet should be light, avoid fat, sweet and thick flavors, avoid sweets, seafood and hot fruits, and advise to eat more vegetables. Avoid scalding with hot water, avoid washing the affected area with soap and other such substances. Avoid scratching to prevent infection.
2、无明显用药禁忌、无敏感性皮肤者。2. Those with no obvious drug contraindications and sensitive skin.
(四)治疗结果(4) Treatment results
治疗时间:2周Treatment time: 2 weeks
疗效判定:结果如下表1所示。Judgment of curative effect: The results are shown in Table 1 below.
表1 90例患者经过2周治疗后的疗效Table 1 The curative effect of 90 patients after 2 weeks of treatment
可见,本发明的药物有效率高,可以有效治疗湿疹。It can be seen that the medicine of the present invention has high effective rate and can effectively treat eczema.
不良反应:用药期间未见不良反应,偶见部分患者治疗后皮肤微红,嘱患者注意水温后情况改善。部分患者查血象、肝肾功能无异常。Adverse reactions: No adverse reactions were seen during the medication period. Occasionally, the skin of some patients was slightly red after treatment. The situation improved after the patients were instructed to pay attention to the water temperature. Some patients had no abnormality in blood examination, liver and kidney function.
方中苍术、黄柏、苦参,均为苦寒去湿之药,以驱除本病祸首——湿邪,湿邪得去则病症不再缠绵难愈。白鲜皮祛风解湿毒而止痒。土茯苓、地肤子、蛇床子祛湿止痒,五倍子收涩为主,收涩破溃的皮损,促进愈合。全方重在除湿,再以风药祛风止痒,湿去痒止病情向愈。Atractylodes atractylodes, Cortex Phellodendri, and Sophora flavescens in the prescription are all medicines for removing dampness from bitter cold, so as to get rid of dampness, the culprit of the disease. If dampness is removed, the disease will no longer be lingering and difficult to heal. The white fresh skin dispels wind, detoxifies dampness and relieves itching. Smilax smilax, Kochia chinensis and Cnidium chinensis dispel dampness and relieve itching, Galla chinensis mainly treats astringent, astringent and ulcerated skin lesions, and promotes healing. The whole prescription focuses on dehumidification, and then uses wind medicine to dispel wind and relieve itching, dampness and itching can relieve the disease and heal.
(五)典型病例(5) Typical cases
患者李某,男性,67岁。患者与两年前,肛门部出现瘙痒症状,抓破后出现潮红糜烂面及渗液,予以皮炎平外涂可暂时缓解,但往往数日后复发,缠绵难愈。刻诊:肛周臀部皮肤破溃,创面潮红,有裂隙、结痂,少许渗液,舌红,舌苔厚腻、脉数。经诊断为湿热内蕴型。治宜清热燥湿。使用本发明的具体实施方法,并建议患者保持患处干燥,饮食清淡,忌肥甘厚味,忌甜食、海鲜食物及热性水果。按上述治疗1疗程,皮损减少,瘙痒减轻,破溃创面几近愈合;再用药1疗程后,皮损、瘙痒消失。Patient Li, male, 67 years old. Two years ago, the patient had itching symptoms in the anus, flushing, erosion and exudate after scratching, which could be relieved temporarily by external application of Dermatitis Ping, but often relapsed after a few days, lingering and difficult to heal. Acute diagnosis: perianal buttocks skin ulceration, wound flushing, fissures, scabs, a little exudate, red tongue, thick and greasy tongue coating, rapid pulse. It was diagnosed as damp-heat intrinsic type. Control suitable heat-clearing and damp-drying. Use the specific implementation method of the present invention, and suggest that the patient keeps the affected part dry, has a light diet, avoids fat, sweet and thick taste, avoids sweets, seafood and hot fruits. According to the above treatment for 1 course, the skin lesions decreased, the itching was alleviated, and the ulcerated wound was almost healed; after another 1 course of treatment, the skin lesions and itching disappeared.
上述实验表明,本发明药物组合物对湿疹患者,尤其是肛周湿疹病患者病情疗效显著,毒副作用小,具有独特的优势和较好的临床应用前景。The above experiments show that the pharmaceutical composition of the present invention has a significant curative effect on eczema patients, especially perianal eczema patients, with little toxic and side effects, and has unique advantages and good clinical application prospects.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610803106.4A CN106266830A (en) | 2016-09-05 | 2016-09-05 | A kind of Chinese medicine composition treating eczema |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610803106.4A CN106266830A (en) | 2016-09-05 | 2016-09-05 | A kind of Chinese medicine composition treating eczema |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106266830A true CN106266830A (en) | 2017-01-04 |
Family
ID=57711158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610803106.4A Pending CN106266830A (en) | 2016-09-05 | 2016-09-05 | A kind of Chinese medicine composition treating eczema |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106266830A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106692817A (en) * | 2017-02-17 | 2017-05-24 | 成都风靡生物科技有限公司 | Ointment medicine for treating eczematous dermatitis and preparation method thereof |
| CN107184703A (en) * | 2017-06-06 | 2017-09-22 | 上海市中医医院 | A kind of three sub- anti-itching lotions and its preparation technology and application |
| CN108283620A (en) * | 2018-03-13 | 2018-07-17 | 兆科药业(广州)有限公司 | A kind of local medicine composition of inhibitors of phosphodiesterase-4 and preparation method thereof |
| CN110151895A (en) * | 2019-06-19 | 2019-08-23 | 孙立峰 | A kind of antibacterial liquid and preparation method thereof and purposes |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102872388A (en) * | 2012-10-13 | 2013-01-16 | 张黎明 | Traditional Chinese medicine composition for treating eczema |
| CN103463539A (en) * | 2013-10-11 | 2013-12-25 | 成都中医药大学附属医院 | Drug for treating eczema, and preparation method and use thereof |
-
2016
- 2016-09-05 CN CN201610803106.4A patent/CN106266830A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102872388A (en) * | 2012-10-13 | 2013-01-16 | 张黎明 | Traditional Chinese medicine composition for treating eczema |
| CN103463539A (en) * | 2013-10-11 | 2013-12-25 | 成都中医药大学附属医院 | Drug for treating eczema, and preparation method and use thereof |
Non-Patent Citations (1)
| Title |
|---|
| 李胜等: ""苦参汤治疗肛周湿疹浅析"", 《健康周刊》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106692817A (en) * | 2017-02-17 | 2017-05-24 | 成都风靡生物科技有限公司 | Ointment medicine for treating eczematous dermatitis and preparation method thereof |
| CN107184703A (en) * | 2017-06-06 | 2017-09-22 | 上海市中医医院 | A kind of three sub- anti-itching lotions and its preparation technology and application |
| CN108283620A (en) * | 2018-03-13 | 2018-07-17 | 兆科药业(广州)有限公司 | A kind of local medicine composition of inhibitors of phosphodiesterase-4 and preparation method thereof |
| CN110151895A (en) * | 2019-06-19 | 2019-08-23 | 孙立峰 | A kind of antibacterial liquid and preparation method thereof and purposes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463539B (en) | A kind of medicine for the treatment of eczema and its production and use | |
| CN103041173B (en) | Traditional Chinese medicine external preparation for curing dermatitis and eczema and preparing method thereof | |
| CN105030621A (en) | Moisturizing and acne removing toner and preparing method thereof | |
| CN106266830A (en) | A kind of Chinese medicine composition treating eczema | |
| CN103071138B (en) | Chinese medicinal composition for treating chronic gastritis as well as preparation method and application | |
| CN110179941A (en) | A kind of Chinese medicine composition that treating eczema and its application | |
| CN105213557A (en) | A kind of traditional Chinese medicine composition for treating eczema | |
| CN103705804B (en) | A kind of Chinese medicine treating acne | |
| CN104491629B (en) | A kind of external medicine composition for treating perianal eczema and preparation method thereof | |
| CN104095970B (en) | A kind of External apply medicinal wine for the treatment of verruca vulgaris | |
| CN107812091B (en) | Traditional Chinese medicine preparation for treating phlebitis caused by chemotherapeutic drugs and preparation method thereof | |
| CN104906466A (en) | Eucalyptus leaf cream and preparation method thereof | |
| CN104056231B (en) | A kind of Chinese medicine composition of cooperation western medical treatment senile skin pruritus | |
| CN106620444A (en) | Pharmaceutical composition for treating eczema and preparation method thereof | |
| CN115400190A (en) | Skin external preparation and preparation method thereof | |
| CN106266152A (en) | A kind of pharmaceutical composition for treating eczema and its preparation method and application | |
| CN103566185B (en) | Chinese medicine composition for the treatment of tinea manus and pedis and preparation method thereof | |
| CN115105550B (en) | Traditional Chinese medicine composition for treating psoriasis and lotion | |
| CN105617322A (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
| CN105535841A (en) | A kind of traditional Chinese medicine for treating acne and preparation method thereof | |
| CN104758358A (en) | A kind of pharmaceutical composition for eczema and preparation method thereof | |
| CN106266859A (en) | The tincture for the treatment of erosive type tinea pedis | |
| CN105343423B (en) | A kind of drug and preparation method thereof for treating eczema | |
| CN103860952A (en) | Traditional Chinese medicine lotion for treating vulva pruritus | |
| CN117503880B (en) | A Chinese medicine composition for treating chronic eczema and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170104 |
|
| RJ01 | Rejection of invention patent application after publication |